Euro Manganese Inc. (ASX:EMN)

SpringWorks Therapeutics Revenue

Euro Manganese had revenue of 874.00K CAD in the quarter ending March 31, 2025, a decrease of -27.05%. This brings the company's revenue in the last twelve months to 3.93M, up 228.14% year-over-year. In the fiscal year ending September 30, 2024, Euro Manganese had annual revenue of 3.22M.

• Revenue (ttm): 3.93M CAD
• Revenue Growth: +228.14%
• P/S Ratio: 6.03
• Revenue / Employee: 65.52K CAD
• Employees: 60
• Market Cap: 26.46M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	3.22M	-	-
Sep 30, 2023	-	-	-
Sep 30, 2022	-	-	-
Sep 30, 2021	-	-	-
Sep 30, 2020	-	-	-